(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Friday that its blood-thinner Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke in patients with an acute ischaemic stroke or high-risk transient ischaemic attack or TIA.The new in
(RTTNews) - Kirin Holdings Company Limited (KNBWF.PK, KNBWY.PK) reported profit to owners of parent company of 71.75 billion yen for the nine months ended September 30, 2020 compared to 33.13 billion yen, last year. Earnings per share was 85.09 yen compared to 37.72 yen. Normaliz
Ocular Therapeutix (OCUL) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.45 per share a year ago. These figures are adjusted for non-recurring items.